Loading company…
Riskpilot
← Back to search
Sign in
Get full access
KBT & Schematerapi SG AB
AB
Active
Org 5592365679
Valhallavägen 2 6 Tr
Tertiary education · NACE 8540
Est. 2020
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 612K
-36% vs 2023
EBITDA margin
58.6%
-58% vs 2023
Equity ratio
69.2%
Financial strength
Net profit 2024
SEK 297K
-55% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
1M
0%
2022
1M
0%
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
SEK 612K
-36%
EBITDA
SEK 359K
-58%
Net profit
SEK 297K
-55%
Total assets
SEK 2,5M
+21%
Equity
SEK 1,7M
+6%
Employees
1
—
Company information
Legal name
KBT & Schematerapi SG AB
Org number
5592365679
Legal form
Aktiebolag
NACE code
8540 · Tertiary education
Founded
13 januari 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Undervisning, handledning, coaching, friskvård
Contact
Address
Valhallavägen 2 6 Tr
Email
gribbe.susanna@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Tertiary education
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
996
773
890
954
612
Staff expenses
—
—
—
−8
−37
EBITDA
832
581
696
848
359
Depreciation & amort.
−0
−0
−0
−5
−5
EBIT
832
581
696
842
354
Net financials
—
—
—
0
7
Profit before tax
624
582
696
843
377
Tax
−134
−125
−144
−176
−79
Net profit
490
457
552
666
297
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
972
1 391
1 637
2 077
2 505
Equity
515
795
1 160
1 631
1 734
Long-term debt
135
292
174
112
277
Short-term debt
114
96
95
125
302
Total debt
249
388
269
237
579
Financial ratios
5-year trend
EBITDA margin
58.6%
This company
15.8%
Market median
+271% vs market
2020
2024
Equity ratio
69.2%
This company
38.2%
Market median
+81% vs market
2020
2024
Return on equity
17.2%
This company
18.4%
Market median
+7% vs market
2020
2024
Net profit margin
48.6%
This company
8.1%
Market median
+500% vs market
2020
2024
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
2020
2024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SI
Stig Ingemar Holmer
Deputy Board Member
2022
AS
Agneta Susanna Gribbe
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of KBT & Schematerapi SG AB also hold positions in
0
other companies.
Person
Role here
Other companies
Stig Ingemar Holmer
Deputy Board Member
0 companies
Agneta Susanna Gribbe
Board of Directors
0 companies